carbostyril has been researched along with Xerostomia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, E; Jeong, JE; Kim, MG; Lee, JY; Park, M | 1 |
| Kawaguchi, M; Ogane, M; Okubo, M; Shinomiya, T; Tsukagoshi, E; Yoshikawa, M | 1 |
| Kawakami, A; Koni, I; Nishinarita, M; Nishiyama, S; Ohta, S; Oka, H; Sawada, S; Sugai, S; Sugiyama, E; Takahashi, H; Takei, M; Umehara, H; Yamaji, K | 1 |
1 trial(s) available for carbostyril and Xerostomia
| Article | Year |
|---|---|
Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjögren's syndrome: a double-blind placebo-controlled multicenter trial.
Topics: Aged; Alanine; Anti-Inflammatory Agents; Double-Blind Method; Eating; Female; Humans; Male; Middle Aged; Mouth; Prostaglandins; Quinolones; Saliva; Sjogren's Syndrome; Sleep; Treatment Outcome; Xerostomia | 2009 |
2 other study(ies) available for carbostyril and Xerostomia
| Article | Year |
|---|---|
Frequently reported adverse events of rebamipide compared to other drugs for peptic ulcer and gastroesophageal reflux disease.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Alanine; Gastroesophageal Reflux; Humans; Peptic Ulcer; Quinolones; Xerostomia | 2022 |
Rebamipide, an anti-ulcerative drug, inhibits induction of salivary dysfunction by benzodiazepines.
Topics: Alanine; Animals; Anti-Ulcer Agents; Central Nervous System Agents; Diazepam; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; Quinolones; Rats; Rats, Wistar; Treatment Outcome; Xerostomia | 2017 |